James Paul Rickey
CIK: 0001606243
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BRVE
Braveheart Bio, Inc.
Officer
Discretionary Trading P&L
Holdings
About Rickey James Paul
Rickey James Paul (SEC CIK 0001606243) files insider reports with the SEC as Chief Financial Officer of Braveheart Bio, Inc. (BRVE).
Signal8 holds 2 ownership filings by Rickey James Paul (1 Form 3, 1 Form 4), filed between Aug 5, 2026 and Aug 7, 2026. Those filings report 2 transactions, from Aug 5, 2026 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rickey James Paul's filings is in SAN FRANCISCO, CA.
Recent filings by Rickey James Paul
Other insiders filing for Braveheart Bio, Inc. (BRVE)
- Agarwala Vineeta, Director
- AH Bio Fund IV, L.P., 10% Owner
- Chimovits Erez, Director
- ORBIMED ADVISORS LLC, Director
- Jiangsu Hengrui Pharmaceuticals Co., Ltd., 10% Owner
- Forbion Growth Opportunities Fund III Cooperatief U.A., 10% Owner